Effects of cholic acid on blood pressure and production of vascular aldosterone and corticosterone

被引:16
作者
Wu, PS [1 ]
Zhang, YS [1 ]
Liu, YL [1 ]
Wang, X [1 ]
Guo, ZG [1 ]
Zhang, YH [1 ]
Liang, XW [1 ]
Lai, WY [1 ]
机构
[1] Nangfang Hosp, Dept Cardiol, Guangzhou 510515, Peoples R China
关键词
cholic acid; hypertension; 11 beta-hydroxysteroid dehydrogenase; aldosterone synthase; vascular aldosterone; vascular corticosterone;
D O I
10.1016/S0039-128X(99)00005-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aims of this study were to search for the role of cholic acid in the regulation blood pressure of humans and rats and to investigate the effects of cholic acid on the production of vascular aldosterone and corticosterone in rats. Levels of serum total bile acids were measured by an enzymic spectrophotometeric method in normal controls, patients with essential hypertension, and in Wistar and spontaneously hypertensive rats. Levels in essential hypertension (7.3 +/- 3.4 mu mol/l, n = 88) were higher than those of normal subjects (4.9 +/- 3.3 mu mol/l, n = 86), and levels in SHR (13.9 +/- 3.8 mu mol/l, n = 11) were slightly increased, bur not significantly different from Wistar rats (10.4 +/- 5.1 mu mol/l, n = 12). Male Wistar rats received cholic acid 80 mg/kg/day, orally, for 30 days, and blood pressure was monitored by a pressure transducer. Systolic blood pressure increased in Wistar rats treated with cholic acid compared to control rats. Mesenteric artery perfusion ex vivo was performed, and presser responses to norepinephrine were determined in Wistar rats. The presser responses to norepinephrine in mesenteric arteries treated with cholic acid were significantly increased. The perfusate from the mesenteric arteries was collected and applied to a Sep-Pak C 18 cartridge column for reverse phase high performance liquid chromatography, and levels of both aldosterone and corticosterone: were determined by radioimmunoassay. Levels of aldosterone were decreased bur those of corticosterone increased in the perfusate from arteries treated with cholic acid. Reverse transcriptase polymerase chain reaction showed that cholic acid inhibited the expression of 11 beta-HSD2 and CYP11B2 mRNA in mesenteric arteries. These results reveal that cholic acid is able to induce hypertension and provide evidence that cholic acid inhibits the transcription of both 11 beta-HSD2 and CYP11B2 in vasculature, leading to lower aldosterone and higher corticosterone production in vessels and increased vasoconstrictor responses to norepinephrine. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 19 条
[1]   ENDOGENOUS INHIBITORS OF 11-BETA-OHSD - EXISTENCE AND POSSIBLE SIGNIFICANCE [J].
BUHLER, H ;
PERSCHEL, FH ;
FITZNER, R ;
HIERHOLZER, K .
STEROIDS, 1994, 59 (02) :131-135
[2]   LOCALIZATION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR [J].
EDWARDS, CRW ;
BURT, D ;
MCINTYRE, MA ;
DEKLOET, ER ;
STEWART, PM ;
BRETT, L ;
SUTANTO, WS ;
MONDER, C .
LANCET, 1988, 2 (8618) :986-989
[3]   MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED [J].
FUNDER, JW ;
PEARCE, PT ;
SMITH, R ;
SMITH, AI .
SCIENCE, 1988, 242 (4878) :583-585
[4]  
JUNJI N, 1992, BIOCHEM BIOPH RES CO, V188, P719
[5]   ISOZYMES OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE - WHICH ENZYME ENDOWS MINERALOCORTICOID SPECIFICITY [J].
KROZOWSKI, ZS ;
PROVENCHER, PH ;
SMITH, RE ;
OBEYESEKERE, VR ;
MERCER, WR ;
ALBISTON, AL .
STEROIDS, 1994, 59 (02) :116-120
[6]   POSSIBLE ENDOGENOUS REGULATORS OF STEROID INACTIVATING ENZYMES AND GLUCOCORTICOID-INDUCED NA+ RETENTION [J].
LATIF, SA ;
HARTMAN, LR ;
SOUNESS, GW ;
MORRIS, DJ .
STEROIDS, 1994, 59 (06) :352-356
[7]  
MASHIGE F, 1981, CLIN CHEM, V27, P1352
[8]   PARTICIPATION OF VASCULAR PROSTACYCLIN FOR THE PATHOGENESIS OF EXPERIMENTAL GLUCOCORTICOID HYPERTENSION IN RATS [J].
MIYAMORI, I ;
YASUHARA, S ;
IKEDA, M ;
KOSHIDA, H ;
TAKEDA, Y ;
MORISE, T ;
NAGAI, K ;
OKAMOTO, S ;
TAKEDA, R .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1985, 7 (04) :513-524
[9]   11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
MONDER, C ;
WHITE, PC .
VITAMINS AND HORMONES, VOL 47: ADVANCES IN RESEARCH AND APPLICATIONS, 1993, 47 :187-271
[10]   Endogenous 11 beta-hydroxysteroid dehydrogenase inhibitors and their role in glucocorticoid Na+ retention and hypertension. [J].
Morris, DJ ;
Souness, GW .
ENDOCRINE RESEARCH, 1996, 22 (04) :793-801